Viewing Study NCT02328261


Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2026-01-09 @ 1:39 PM
Study NCT ID: NCT02328261
Status: UNKNOWN
Last Update Posted: 2014-12-31
First Post: 2014-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module